{
    "title": "115_s2931",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``National Milestones to Measure \nProgress in Ending the Opioid Epidemic Act of 2018''.\n\nSEC. 2. NATIONAL MILESTONES TO MEASURE SUCCESS IN CURTAILING THE OPIOID \n              EPIDEMIC.\n\n    (a) In General.--Not later than 180 days after the date of \nenactment of this Act, the Secretary of Health and Human Services \n(referred to in this Act as the ``Secretary''), in consultation with \nthe Administrator of the Drug Enforcement Administration and the \nDirector of the Office of National Drug Control Policy, shall develop \nnational indicators to measure success in curtailing the opioid \nepidemic, with the goal of significantly reversing the toll of opioid \nmisuse and opioid-related morbidity and mortality in the United States \nwithin 5 years of such date of enactment (referred to in this section \nas the ``national milestones'').\n    (b) National Milestones To End the Opioid Epidemic.--The national \nmilestones under subsection (a) shall include the following:\n            (1) The establishment of not fewer than 10 indicators or \n        metrics to accurately and expediently measure progress in \n        meeting the goal described in subsection (a)(1), which shall \n        include--\n                    (A) a reduction in fatal and non-fatal opioid \n                overdoses;\n                    (B) a reduction in emergency room visits related to \n                opioid misuse and abuse;\n                    (C) an increase in public and provider education, \n                including a focus on reducing stigma associated with \n                opioid use disorder;\n                    (D) an increase in the number of individuals in \n                sustained recovery from opioid use disorder;\n                    (E) a reduction in the number of co-infections \n                associated with injection drug use, such as HIV, viral \n                hepatitis, and endocarditis, and an expanded capacity \n                to reduce initial infections and enhance access to \n                treatment;\n                    (F) an increase in the number of providers \n                prescribing medically assisted treatment for opioid use \n                disorder in different settings, including primary care, \n                community health centers, jails, and prisons;\n                    (G) an increase in the number of harm reduction \n                organizations, including syringe services programs and \n                naloxone distribution programs;\n                    (H) an increase in the number of individuals \n                admitted to opioid use disorder treatment; and\n                    (I) additional indicators or metrics, such as \n                metrics pertaining to specific populations, including \n                women and children, American Indians and Alaskan \n                Natives, individuals living in rural and non-urban \n                areas, and justice-involved populations, that would \n                further clarify the progress made in addressing the \n                opioid misuse and abuse epidemic, as the Secretary \n                determines appropriate.\n            (2) A reasonable goal, such as a percentage decrease or \n        other specified metric, that signifies progress in meeting the \n        goal described in subsection (a), and annual targets to help \n        achieve that goal.\n    (c) Extension of Period.--If the Secretary determines that the goal \ndescribed in subsection (a) will not be achieved with respect to any \nindicator or metric established under subsection (b)(2) within 5 years \nof the date of enactment of this Act, the Secretary may extend the \ntimeline for meeting such goal with respect to that indicator or \nmetric. The Secretary shall include with any such extension a rationale \nfor why additional time is needed and a description of changes the \nSecretary will make in order to achieve such goal with respect to the \nindicator or metric.\n    (d) Reports.--During the 5-year period described in subsection (a) \nor such extended period as the Secretary may determine under subsection \n(c), the Secretary shall--\n            (1) submit to Congress annual reports on the national \n        milestones; and\n            (2) make each such report publicly available.\n    (e) Annual Status Update.--Beginning one year after submission of \nthe report under subsection (d) and for each year thereafter that a \nreport is required under such subsection, the Secretary shall provide \nan update to Congress on the progress of Federal agencies in achieving \nthe goals detailed in the national milestones. Each such update shall \ninclude--\n            (1) the total Federal investment in programs addressing the \n        opioid epidemic and the amount invested in each program, both \n        by fiscal year and, for programs created after fiscal year \n        2015, the total spent since the program's creation;\n            (2) an evaluation of the most and least effective Federal \n        programs intended to respond to the opioid crisis;\n            (3) the progress made in the first year or since the \n        previous report, as applicable, in meeting each indicator or \n        metric in the national milestones; and\n            (4) the Secretary's proposal for meeting each specified \n        indicator or metric in the proceeding year."
}